Navigation path

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cambodia
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Faroe Islands
  Finland
  France
  Gambia
  Georgia

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cambodia
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Faroe Islands
  Finland
  France
  Gambia
  Georgia


  

Published: 10 November 2017  
Related theme(s) and subtheme(s)
Health & life sciencesMedical research
Research policyHorizon 2020
Special CollectionsCancer
Countries involved in the project described in the article
Germany  |  Netherlands  |  Norway  |  Sweden  |  United Kingdom
Add to PDF "basket"

Advancing the treatment of melanoma

There is still a lot to learn about the genetic changes that occur as melanoma tumours form - and about the body's response to this illness. Greater understanding could help to predict how individual tumours are likely to respond to various combinations of therapies. An EU-funded network is training young researchers who are exploring this issue.

Photo of a female doctor examining a young girl

© zinkevych - fotolia.com

MelGen is enabling more than a dozen young scientists from universities around Europe to hone their research skills, in a bid to help take targeted treatment of melanoma another step ahead. It is a network backed by the EU’s Marie SkÅ‚odowska-Curie fellowship programme, as part of plan to advance a scientific discipline while fostering excellence and business innovation in a new generation of researchers.

Networks supported by this type of grant are expected to support young researchers not only with training in their chosen field, but also with opportunities to develop their creativity, entrepreneurship and innovation capabilities. They typically involve partners from several sectors, enabling participants to experience different types of research setting.

Work in MelGen focuses on two aspects of melanoma that are crucial to survival. In addition to focusing on genomic alterations associated with tumour development, the research encompasses the immune system’s response to the disease so as to improve understanding of the tumours’ ability to suppress this response.

While the research relates to melanoma, any insights it may generate might also be relevant to other types of tumour. Ultimately, the training MelGen is providing could help to refine the treatment of a variety of cancers.

Led by the University of Leeds, the network involves a variety of academic and commercial partners who are collaborating to offer the participating early stage researchers an innovative, interdisciplinary training programme. It was set up in June 2016 for a period of four years.

Project details

  • Project acronym: MelGen
  • Participants: United Kingdom (Coordinator), Germany, Sweden, Netherlands, Norway
  • Project N°: 641458
  • Total costs: € 3 988 365
  • EU contribution: € 3 988 365
  • Duration: 1 June 2015 to 31 May 2019

See also

 

Convert article(s) to PDF

No article selected


loading


Search articles

Notes:
To restrict search results to articles in the Information Centre, i.e. this site, use this search box rather than the one at the top of the page.

After searching, you can expand the results to include the whole Research and Innovation web site, or another section of it, or all Europa, afterwards without searching again.

Please note that new content may take a few days to be indexed by the search engine and therefore to appear in the results.

Print Version
Share this article
See also
Project website
Project details


  Top   Research Information Center
 
Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cambodia
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Faroe Islands
  Finland
  France
  Gambia
  Georgia

Countries
Countries
  Algeria
  Argentina
  Australia
  Austria
  Bangladesh
  Belarus
  Belgium
  Benin
  Bolivia
  Botswana
  Brazil
  Bulgaria
  Burkina Faso
  Cambodia
  Cameroon
  Canada
  Cape Verde
  Chile
  China
  Colombia
  Costa Rica
  Croatia
  Cyprus
  Czech Republic
  Denmark
  Ecuador
  Egypt
  Estonia
  Ethiopia
  Faroe Islands
  Finland
  France
  Gambia
  Georgia